Yun-Peng Liu (Yunpeng Liu)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 11

Top Topics

Liver Metastases

Epidermal Growth Factor Receptor

Top Venues

OncoTargets and therapy

Journal of cellular and molecular medicine

Cancer management and research

This page only lists publications with an associated author ORCID identifier.

Publications

Yujing Yang, Xinye Shao, Zhi Li, Lingyun Zhang, Bowen Yang, Bo Jin, Xuejun Hu, Xiujuan Qu, Xiaofang Che, Yun-Peng Liu
Prognostic heterogeneity of Ki67 in non-small cell lung cancer: A comprehensive reappraisal on immunohistochemistry and transcriptional data. Journal of cellular and molecular medicine 28 (14) (2024)
Yujing Yang, Xinye Shao, Zhi Li, Lingyun Zhang, Bowen Yang, Bo Jin, Xuejun Hu, Xiujuan Qu, Xiaofang Che, Yun-Peng Liu
Prognostic heterogeneity of Ki67 in non-small cell lung cancer: A comprehensive reappraisal on immunohistochemistry and transcriptional data. Journal of cellular and molecular medicine 28 (14) (2024)
Dongyang Li, Yue Jin, Xin He, Jian Deng, Wenqing Lu, Zichang Yang, Xueying Zheng, Kezuo Hou, Shiying Tang, Bowen Bao, Jie Ren, Xiaojie Zhang, Jin Wang, Hongfei Yan, Xiujuan Qu, Yun-Peng Liu, Xiaofang Che
Hypoxia-induced LAMB2-enriched extracellular vesicles promote peritoneal metastasis in gastric cancer via the ROCK1-CAV1-Rab11 axis. Oncogene (2024)
Tao Jiang, Qiqi Jin, Jiahao Wang, Feng-Ying Wu, Jian Chen, Gongyan Chen, Yunchao Huang, Jianhua Chen, Ying Cheng, Qi-Ming Wang, Yue-Yin Pan, Jian-Ying Zhou, Jianhua Shi, Xingxiang Xu, LiZhu Lin, Wei Zhang, Yiping Zhang, Yun-Peng Liu, Yong Fang, Jifeng Feng, Zhehai Wang, Sheng Hu, Jian Fang, Yongqian Shu, Jiu-Wei Cui, Yi Hu, Wenxiu Yao, Xingya Li, Xiaoyan Lin, Rui Wang, Yongsheng Wang, Wei Shi, Gaohua Feng, Jun Ni, Beibei Mao, Dandan Ren, Huaibo Sun, Henghui Zhang, Luo-Nan Chen, Cai-Cun Zhou, Shengxiang Ren
HLA-I evolutionary divergence confers response to PD-1 blockade plus chemotherapy in untreated advanced non-small-cell lung cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Yu Cheng, Gang Wu, Simeng Zhang, Yun-Peng Liu, Jinglei Qu, Xiujuan Qu
Complete Pathologic Response of Multiple Liver Metastases and Clinical Complete Response of Rectal Cancer in a Patient with Ataxia-Telangiectasia Mutated Gene Mutations After XELOXIRI Plus Bevacizumab: A Case Report. OncoTargets and therapy 14 (2021)
Rui Ma, Xiujuan Qu, Xiaofang Che, Bowen Yang, Ce Li, Kezuo Hou, Tianshu Guo, Jiawen Xiao, Yun-Peng Liu
Comparative Analysis and in vitro Experiments of Signatures and Prognostic Value of Immune Checkpoint Genes in Colorectal Cancer. OncoTargets and therapy 14 (2021)
Shuo Wang, Xiujuan Qu, Lili Cao, Xuejun Hu, Kezuo Hou, Yun-Peng Liu, Xiaofang Che
Assessment of Nine Driver Gene Mutations in Surgically Resected Samples from Patients with Non-Small-Cell Lung Cancer. Cancer management and research 12 (2020)
Liuying Zhu, Yuanhe Wang, Yang Zhou, Qian Dong, Yun-Peng Liu, Jingdong Zhang
RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer. BioMed research international 2020 (2020)
Na Song, Ming Bai, Xiaofang Che, Zhi Li, Wei Jing, Ce Li, Zan Teng, Xiujuan Qu, Yun-Peng Liu
PD-L1 upregulation accompanied with epithelial-mesenchymal transition attenuates sensitivity to ATR inhibition in p53 mutant pancreatic cancer cells. Medical oncology (Northwood, London, England) 37 (5) (2020)
Yun-Ting Zhu, Zan Teng, Yi-Fan Zhang, Wei Li, Li-Xia Guo, Yun-Peng Liu, Xiu-Juan Qu, Quan-Ren Wang, Si-Yuan Mao, Xiao-Yan Chen, Da-Fang Zhong
Effects of Apatinib on the Pharmacokinetics of Nifedipine and Warfarin in Patients with Advanced Solid Tumors. Drug design, development and therapy 14 (2020)
Jing Liu, Bo Jin, Hang Su, Xiujuan Qu, Yun-Peng Liu
Afatinib helped overcome subsequent resistance to osimertinib in a patient with NSCLC having leptomeningeal metastasis baring acquired EGFR L718Q mutation: a case report. BMC cancer 19 (1) (2019)